Xylem Inc. (NYSE:XYL) Shares Bought by Impax Asset Management Group plc

Impax Asset Management Group plc grew its position in Xylem Inc. (NYSE:XYL) by 231.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,561,661 shares of the industrial products company’s stock after acquiring an additional 3,883,845 shares during the period. Xylem accounts for 2.9% of Impax Asset Management Group plc’s portfolio, making the stock its 4th largest holding. Impax Asset Management Group plc owned about 2.29% of Xylem worth $644,039,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Swedbank AB lifted its position in Xylem by 22.8% during the 3rd quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company’s stock worth $403,953,000 after buying an additional 554,609 shares in the last quarter. Blue Trust Inc. raised its stake in shares of Xylem by 270.4% in the third quarter. Blue Trust Inc. now owns 1,000 shares of the industrial products company’s stock worth $136,000 after acquiring an additional 730 shares during the last quarter. Private Advisor Group LLC lifted its position in shares of Xylem by 24.8% during the third quarter. Private Advisor Group LLC now owns 10,969 shares of the industrial products company’s stock worth $1,481,000 after purchasing an additional 2,180 shares in the last quarter. International Assets Investment Management LLC grew its stake in shares of Xylem by 13,454.8% during the third quarter. International Assets Investment Management LLC now owns 75,229 shares of the industrial products company’s stock valued at $10,158,000 after purchasing an additional 74,674 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. increased its holdings in shares of Xylem by 34.8% in the third quarter. Hennion & Walsh Asset Management Inc. now owns 3,419 shares of the industrial products company’s stock valued at $462,000 after purchasing an additional 883 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Xylem Stock Down 1.9 %

Shares of NYSE XYL opened at $127.32 on Monday. The firm has a 50 day moving average price of $121.81 and a 200 day moving average price of $127.19. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.76. The stock has a market cap of $30.93 billion, a P/E ratio of 34.79, a P/E/G ratio of 2.33 and a beta of 1.07. Xylem Inc. has a 52-week low of $113.26 and a 52-week high of $146.08.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, February 4th. The industrial products company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.12 by $0.06. The business had revenue of $2.30 billion during the quarter, compared to analysts’ expectations of $2.18 billion. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.99 EPS. Analysts expect that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 19th. Investors of record on Tuesday, February 18th will be given a $0.40 dividend. The ex-dividend date is Tuesday, February 18th. This is a positive change from Xylem’s previous quarterly dividend of $0.36. This represents a $1.60 annualized dividend and a dividend yield of 1.26%. Xylem’s payout ratio is currently 43.72%.

Analyst Upgrades and Downgrades

XYL has been the topic of a number of recent research reports. Citigroup lowered Xylem from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 5th. Wolfe Research reiterated a “peer perform” rating on shares of Xylem in a report on Thursday, December 12th. Robert W. Baird lifted their price objective on Xylem from $139.00 to $148.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 5th. Stifel Nicolaus cut their target price on shares of Xylem from $166.00 to $150.00 and set a “buy” rating on the stock in a research report on Friday, January 24th. Finally, Royal Bank of Canada lowered their price target on shares of Xylem from $163.00 to $162.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $149.90.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.